Biomarkers play a pivotal role in advancing ADC therapies, showcasing their versatility and impact. At Accurant Biotech, we specialize in ADC solutions, offering expertise tailored to your needs. Let us help accelerate your development journey ?? . Contact us at [email protected] for more details or to start a conversation! #biomarker #ADC #CDx #IHC #CRO #clinicaltrial
关于我们
Accurant Biotech is an outsourcing organization (CRO) focusing on large molecule bioanalysis services. We collaborate with global pharma and biotech companies. Our services include preparation bioanalysis reagent, development, and validation of bioanalytical methodology and sample analysis in compliance with GLP regulations. Accurant Biotech has operations in 3 different cities in China and the US. The global operation setup enables Accurant Biotech to provide streamline services for multi-site clinical trials to support biologics drug development. For business inquiry, please contact [email protected]
- 网站
-
https://www.accurantbiotech.com/
Accurant Biotech, Inc 的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- Cranbury，New Jersey
- 类型
- 私人持股
- 创立
- 2017
地点
Accurant Biotech, Inc 员工
动态
-
We are thrilled to share that our very own Cansu Dernek, Test Facility Manager at Accurant Biotech, has been featured in the AAPS Newsletter! ?? Cansu’s insights into building a successful career in biotech and pharma are a testament to her dedication, expertise, and the inspiring balance she brings as a professional, a wonderful colleague, and a devoted mother. We are so proud to have her on our team! Check out the full interview to learn more about her journey thus far: https://lnkd.in/ekzwz-jY #Biotech #Pharma #CareerSuccess #AAPS #WomenInSTEM #AccurantBiotech
Career Success: An interview with Cansu Dernek, Accurant Biotech, Inc
aapsnewsmagazine.org
-
At Accurant Biotech, we offer comprehensive mIHC service to support your clinical trial needs. Please reach out to BD team at [email protected] to learn more.?? #mIHC #CRO #Clinical #bioanalysis
Multiplexed Immunohistochemistry (mIHC): Accelerating Clinical Development of Anti-Tumor Drugs
Accurant Biotech, Inc ，发布于领英
-
At Accurant Biotech, we offer comprehensive mIHC service to support your clinical trial needs. Please reach out to BD team at [email protected] to learn more.?? #mIHC #CRO #Clinical #bioanalysis
Multiplexed Immunohistochemistry (mIHC): Accelerating Clinical Development of Anti-Tumor Drugs
Accurant Biotech, Inc ，发布于领英
-
Congratulations to EvolveImmune Therapeutics on this remarkable achievement!
We are thrilled to announce our collaboration and option-to-license agreement with AbbVie to develop multispecific biologics for multiple targets in #oncology. The partnership will leverage our proprietary biotherapeutics platform for the treatment of malignancies with high unmet needs. Kudos to our team members for their dedication to pioneering science and steadfast commitment to patients! #ForPatients #EvolveImmune #Collaboration #Team https://lnkd.in/ej8X8hwt
AbbVie and EvolveImmune Therapeutics Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Cancer Biotherapeutics
globenewswire.com
-
Awesome turnout at Accurant Biotech’s booth during PharmSci360! Here Shi Shi of 23andMe chats with our CEO & Co-Founder, Xiao-Yan Cai, Ph.D., and our Business Development Specialist, Kevin Kelley, MBS. We’re thrilled to connect with so many pioneers in the pharma and biotech space. Contact us to explore how our services can streamline your clinical trials and bring groundbreaking therapies to patients faster. Together, we can drive change! #PharmaConvention #ClinicalResearch #DrugDevelopment #CRO
-
-
Exciting moments at Accurant Biotech’s booth at PharmSci360! Sitaram Velaga of Kenox Pharmaceuticals, Inc stops by to learn more about our large molecule bioanalysis & CMC services. It’s been incredible connecting with industry leaders and innovators who share our passion for advancing clinical & non-clinical research. If you’re at the convention, swing by to learn how our tailored solutions can accelerate your drug development and bring breakthrough therapies to patients faster. Let’s collaborate to drive innovation together! #PharmaConvention #ClinicalResearch #DrugDevelopment #CRO”
-
-
The Accurant Biotech, Inc team is off to a great start at #AAPS #PharmaSci360 in Salt Lake City! If you’re attending, be sure to stop by Booth 1725 to meet our Co-founder, Xiao-Yan Cai, Ph.D., and the team. We’re excited to discuss how we can support your #bioanalytical needs. Looking forward to connecting!
-
-
Why dPCR is a Critical Bioanalytical Method in the Growing CGT Field: Key Validation Considerations from Accurant Biotech, Inc #CGT #bioanalytical #dPCR #CRO #Clinical
Digital PCR (dPCR) and consideration for method validation
Accurant Biotech, Inc ，发布于领英
-
?? Check out our co-founder, Xiao-Yan Cai, Ph.D., sharing her thoughts on the future of bioanalysis in the interview with Pharmaceutical Technology! Stop by booth 1725 to learn more. #AAPS #PharmSci360 #Bioanalysis
Accurant Biotech, Inc Co-Founder and CEO Xiao-Yan Cai, Ph.D. spoke to Pharmaceutical Technology about the future of #bioanalysis. Make sure you stop by their booth (no. 1725) in the #PharmSci360 Solution Center, open today 8:30 am-5 pm MT. https://lnkd.in/eHX5Dfzz
AAPS PharmSci 360 2024: The Future of Bioanalysis
pharmtech.com